MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
7.30
-0.38 (-4.95%)
At close: Jan 30, 2026

MaaT Pharma Revenue

MaaT Pharma had revenue of 2.43M EUR in the half year ending June 30, 2025, with 76.12% growth. This brings the company's revenue in the last twelve months to 3.92M, up 52.55% year-over-year. In the year 2024, MaaT Pharma had annual revenue of 3.22M with 44.34% growth.

Revenue (ttm)
3.92M
Revenue Growth
+52.55%
P/S Ratio
29.98
Revenue / Employee
60.34K
Employees
65
Market Cap
117.57M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.22M988.00K44.34%
Dec 31, 20232.23M798.00K55.80%
Dec 31, 20221.43M458.00K47.12%
Dec 31, 2021972.00K--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cellectis70.36M
Genfit45.13M
Adocia12.88M
Fermentalg12.78M
Innate Pharma12.64M
Transgene7.58M
Sensorion5.65M
ABIONYX Pharma4.33M
Revenue Rankings